BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

SLC27A2 inhibition for lymphoma, lung, colorectal and cervical cancers

Claire Quang
April 23, 2019 5:10 PM UTC

INDICATION: Lung cancer; T cell lymphoma; colorectal cancer; cervical cancer...

BCIQ Company Profiles

Wistar Institute

BCIQ Target Profiles

Colony-stimulating factor 1 receptor (CSF1R) (C-FMS) (CD115)

Cytotoxic T-lymphocyte associated protein 4 (CTLA-4) (CTLA4) (CD152)

Solute carrier family 27 member 2 (SLC27A2)

BCIQ Company Profiles

Wistar Institute

BCIQ Target Profiles

Colony-stimulating factor 1 receptor (CSF1R) (C-FMS) (CD115)

Cytotoxic T-lymphocyte associated protein 4 (CTLA-4) (CTLA4) (CD152)

Solute carrier family 27 member 2 (SLC27A2)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2026 BioCentury Inc. All Rights Reserved.
Copyright © 2026 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS